Pistoia Alliance Partners with Matador
Thursday, June 15, 2023
The Pistoia Alliance has recently announced a partnership with Matador to facilitate collaborative efforts in the Japanese market, focusing on pre-competitive collaboration.
This strategic collaboration aims to enhance the adoption of new technologies and leverage Japan's research and development expertise in key areas such as targeted immunotherapy, the human microbiome, and neurology. Moreover, it aims to promote advancements in pharmaceutical research and development and drive progress in the field.
By combining forces, the Pistoia Alliance and Matador aims to leverage combined resources and expertise to support member organisations in accelerating their research efforts and provide access to a comprehensive global pharmaceutical ecosystem.
The partnership between the Pistoia Alliance and Matador aims to establish networking and interest groups that cater specifically to the Japanese market. These groups will operate in the local language and time zone, which will directly benefit member organisations in the region.
Partnering with the Pistoia Alliance will grant members access to global expertise in these domains, further enhancing their capabilities and opportunities for collaboration.
